Clinical Trials
- Breast Cancer
Optimizing surgical decisions in young adults with breast cancer
- Breast Cancer
I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)
- Breast Cancer
Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive Breast Cancer
- Breast Cancer
Lifestyle Factors among Breast Cancer Survivors
- Breast Cancer
An observational study of circulating tumor DNA in triple negative breast cancers with residual disease after standard neoadjuvant treatment.
Birth Control and Genetics Study
- Ages18 years - 45 years
- GenderFemale only
- Breast Cancer
Use of DiviTum -TKa as a biomarker assay for CDK4/6 inhibitor medication compliance and drug-drug interactions assessment and intervention in HR-positive metastatic breast cancer patients
- Breast Cancer
Phase 3, Open-Label, Randomized, Study Comparing Gedatolisib Combined With Fulvestrant & With or Without Palbociclib to Standard-of-Care Therapies in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination w/Non-Steroidal Aromatase Inhibitor Therapy
- Breast Cancer
A Phase 1b/2, Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer
- COVID-19 Inpatient, COVID-19 Outpatient
Biological, Behavioral, and Genetic Mechanisms in the Intergenerational Transmission of Toxic Stress
- Ages18 years and older
- GenderFemale only